Share Your Research, Maximize Your Social Impacts
Antidiabetic, Antihypertensive and Statin Medication Use in Metabolic Syndrome
Journal: International Journal of Pharmaceutical Sciences and Developmental Research (Vol.2, No. 1)Publication Date: 2016-12-23
Authors : Ie Butkowski E Brix L Al-Aubaidy HA Kiat H; Jelinek HF;
Page : 006-011
Keywords : ;
Source : Download
Find it from : Google Scholar
Abstract
Background: Metabolic syndrome (MetS) is characterised by a cluster of metabolic risk factors, which eventually increases the risk of diabetes and cardiovascular disease (CVD). The aim of the current study was to investigate medication use in outpatient communities with respect to the occurrence of these metabolic risk factors as defined by ATPIII.
Other Latest Articles
- Diabesity Increases Inflammation and Oxidative Stress
- Edaravone Protects against Vascular Oxidative Damage Induced by AAPH in Chick Embryo
- Synergistic Action in Oral Glucose Tolerance Tests between Spilanthes Calva Aerial Parts and Tubers of Colocasia Esculenta
- Morphofunctional and Metabolic Alterations after Orchiectomy
- Current Knowledge on Psychic Stress in Surgical Procedures
Last modified: 2019-04-25 21:11:40